Tomoko Furuya

Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems

Eisaku Kondo, Ken Saito, Yuichi Tashiro et al. · Nature Communications · 2012 · 154 citations · Full text

Cell-based Drug Delivery, Peptide Therapeutic, Drug Delivery Systems +6

Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer

Yoshiaki Yamamoto, Hideyasu Matsuyama, Yasuyo Chochi et al. · Cancer Genetics and Cytogenetics · 2007 · 107 citations

Urology, Oncology, Genitourinary Cancer +8

Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH

Kiichiro Hashimoto, Naohide Mori, Takao Tamesa et al. · Modern Pathology · 2004 · 101 citations · Full text

Array Cgh, Conventional Cgh, Hepatology +10

Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype

Masumi Yanagawa, Kenzo Ikemot, Shigeto Kawauchi et al. · BMC Research Notes · 2012 · 100 citations · Full text

Gain of 5p15.33 Is Associated with Progression of Bladder Cancer

Yoshiaki Yamamoto, Yasuyo Chochi, Hideyasu Matsuyama et al. · Oncology · 2007 · 86 citations